Biotech · Private company

GW Pharmaceuticals Ltd

Track this companyFree. Adds GW Pharmaceuticals Ltd to your Dealase workspace and tells you when its record changes.

Clinical trials40 recruiting or active

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Clinical trials4

CBDV vs Placebo in Children and Adults up to Age 30 With Prader-Willi Syndrome (PWS)PHASE2 · TERMINATED · started Nov 23, 2020ClinicalTrials.gov NCT03848481 · fetched Nov 12, 2026
A Long-term Safety Study of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett SyndromePHASE3 · TERMINATED · started Feb 28, 2020ClinicalTrials.gov NCT04252586 · fetched Nov 12, 2026
Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)PHASE2 · COMPLETED · started Apr 12, 2019ClinicalTrials.gov NCT03202303 · fetched Nov 12, 2026
An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)PHASE3 · COMPLETED · started Aug 31, 2016ClinicalTrials.gov NCT02544750 · fetched Nov 12, 2026